David B. Bylund

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacology, Mental Health, Behavioral Psychology
Google:
"David Bylund"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bylund DB, Enna SJ. (2018) Receptor Binding Assays and Drug Discovery. Advances in Pharmacology (San Diego, Calif.). 82: 21-34
Bylund DB, Toews ML. (2011) Radioligand binding methods for membrane preparations and intact cells. Methods in Molecular Biology (Clifton, N.J.). 746: 135-64
Montgomery MD, Bylund DB. (2010) Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells. British Journal of Pharmacology. 159: 820-30
Balogh B, Szilágyi A, Gyires K, et al. (2009) Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study. Neurochemistry International. 55: 355-61
Reed AL, Anderson JC, Bylund DB, et al. (2009) Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology. 205: 249-59
Deupree JD, Burke WJ, Bylund DB. (2008) Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration. Bmc Pharmacology. 8: 17
Reed AL, Happe HK, Petty F, et al. (2008) Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology. 197: 433-41
Kozisek ME, Middlemas D, Bylund DB. (2008) The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology. 54: 251-7
Kozisek ME, Middlemas D, Bylund DB. (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacology & Therapeutics. 117: 30-51
Bylund DB, Kozisek ME, Montgomery MD, et al. (2007) Today's research, tomorrow's health: focus on pharmacogenomics. Personalized Medicine. 4: 363-367
See more...